{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT04426201: Phase 2 Interventional Terminated COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03983954: Phase 1 Interventional Recruiting ER+ Breast Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02137343: Phase 3 Interventional Terminated Gastric Cancer
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03736447: Phase 3 Interventional Completed Peanut Allergy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01110720: Phase 2/Phase 3 Interventional Completed Progressive Supranuclear Palsy
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00877656: Phase 2/Phase 3 Interventional Completed T Cell Lymphoma
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00322270: Phase 3 Interventional Completed Thrombosis
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01101581: Phase 1/Phase 2 Interventional Withdrawn Non Hodgkin's Lymphoma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00989586: Phase 1/Phase 2 Interventional Completed Lymphoma
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:PROINSULIN HUMAN [USAN]
Source URL:
Class:
PROTEIN
